Preoperative Trial of Sorafenib in Combination With Cisplatin Followed by Paclitaxel for Early Stage Breast Cancer
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Sorafenib|DRUG: Cisplatin|DRUG: Paclitaxel
Sponsor: Emory University
Collaborators: Amgen|Bayer